The impact of apolipoprotein E on dementia in persons with Down's syndrome.

Coppus, A M W; Evenhuis, H M; Verberne, G-J; Visser, F E; Arias-Vasquez, A; Sayed-Tabatabaei, F A; Vergeer-Drop, J; Eikelenboom, P; van Gool, W A; van Duijn, C M

Coppus, A M W; Evenhuis, H M; Verberne, G-J; Visser, F E; Arias-Vasquez, A; Sayed-Tabatabaei, F A; Vergeer-Drop, J; Eikelenboom, P; van Gool, W A; van Duijn, C M.

Affiliation

Coppus AM; Department of Epidemiology & Biostatistics, Erasmus MC, Rotterdam, The Netherlands.

Neurobiol Aging ; 29(6): 828-35, 2008 Jun.

Article in En | MEDLINE | ID: mdl-17250929

Subject(s)

Apolipoproteins E/genetics; Dementia/epidemiology; Dementia/genetics; Down Syndrome/epidemiology; Down Syndrome/genetics; Risk Assessment/methods; Aged; Aged, 80 and over; Comorbidity; Female; Genetic Predisposition to Disease/genetics; Humans; Male; Middle Aged; Netherlands/epidemiology; Prevalence; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins E / Down Syndrome / Risk Assessment / Dementia Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Neurobiol Aging Year: 2008 Document type: Article Affiliation country: Netherlands Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links